Journal: The Cochrane Database of Systematic Reviews

Article Title: Artesunate plus pyronaridine for treating uncomplicated Plasmodium falciparum malaria

doi: 10.1002/14651858.CD006404.pub2

Figure Lengend Snippet: Kayentao 2012

Article Snippet: Random sequence generation (selection bias) , Low risk , Quote from report: "A computer generated randomisation schedule was provided by Averion AG (Allschwil, Switzerland). Patients were assigned a randomisation code by the investigator in ascending order and allocated to treatment in blocks of nine by study centre.".

Techniques: Microscopy, Pregnancy Test (hCG) Assay, Infection, Formulation, Control, Suspension, Sequencing, Selection

Journal: The Cochrane Database of Systematic Reviews

Article Title: Artesunate plus pyronaridine for treating uncomplicated Plasmodium falciparum malaria

doi: 10.1002/14651858.CD006404.pub2

Figure Lengend Snippet: Poravuth 2011

Article Snippet: Random sequence generation (selection bias) , Low risk , Quote from report: "A computer generated randomisation schedule was provided by Averion AG (Allschwil, Switzerland). Patients were assigned a randomisation code by the investigator in ascending order and allocated to treatment in blocks of nine by study centre.".

Techniques: Control, Sequencing, Selection

Journal: The Cochrane Database of Systematic Reviews

Article Title: Artesunate plus pyronaridine for treating uncomplicated Plasmodium falciparum malaria

doi: 10.1002/14651858.CD006404.pub2

Figure Lengend Snippet: Ringwald 1996

Article Snippet: Random sequence generation (selection bias) , Low risk , Quote from report: "A computer generated randomisation schedule was provided by Averion AG (Allschwil, Switzerland). Patients were assigned a randomisation code by the investigator in ascending order and allocated to treatment in blocks of nine by study centre.".

Techniques: Control, In Vitro, Sequencing, Selection

Journal: The Cochrane Database of Systematic Reviews

Article Title: Artesunate plus pyronaridine for treating uncomplicated Plasmodium falciparum malaria

doi: 10.1002/14651858.CD006404.pub2

Figure Lengend Snippet: Ringwald 1998

Article Snippet: Random sequence generation (selection bias) , Low risk , Quote from report: "A computer generated randomisation schedule was provided by Averion AG (Allschwil, Switzerland). Patients were assigned a randomisation code by the investigator in ascending order and allocated to treatment in blocks of nine by study centre.".

Techniques: Control, In Vitro, Sequencing, Selection

Journal: The Cochrane Database of Systematic Reviews

Article Title: Artesunate plus pyronaridine for treating uncomplicated Plasmodium falciparum malaria

doi: 10.1002/14651858.CD006404.pub2

Figure Lengend Snippet: Rueangweerayut 2012

Article Snippet: Random sequence generation (selection bias) , Low risk , Quote from report: "A computer generated randomisation schedule was provided by Averion AG (Allschwil, Switzerland). Patients were assigned a randomisation code by the investigator in ascending order and allocated to treatment in blocks of nine by study centre.".

Techniques: Control, Sequencing, Selection, Generated, Introduce

Journal: The Cochrane Database of Systematic Reviews

Article Title: Artesunate plus pyronaridine for treating uncomplicated Plasmodium falciparum malaria

doi: 10.1002/14651858.CD006404.pub2

Figure Lengend Snippet: Tshefu 2010

Article Snippet: Random sequence generation (selection bias) , Low risk , Quote from report: "A computer generated randomisation schedule was provided by Averion AG (Allschwil, Switzerland). Patients were assigned a randomisation code by the investigator in ascending order and allocated to treatment in blocks of nine by study centre.".

Techniques: Control, Sequencing, Selection, Generated

Journal: The Cochrane Database of Systematic Reviews

Article Title: Aclidinium bromide for stable chronic obstructive pulmonary disease

doi: 10.1002/14651858.CD010509.pub2

Figure Lengend Snippet: ACCLAIM/COPD I

Article Snippet: Although not explicitly described in the trial reports, from correspondence all Almirall ‐sponsored trials applied a computer generated randomisation schedule which was prepared prior to initiating the trial.

Techniques: Control, Biomarker Discovery, Infection, Comparison, Medications, Sequencing, Selection, Generated, Blocking Assay

Journal: The Cochrane Database of Systematic Reviews

Article Title: Aclidinium bromide for stable chronic obstructive pulmonary disease

doi: 10.1002/14651858.CD010509.pub2

Figure Lengend Snippet: ACCLAIM/COPD II

Article Snippet: Although not explicitly described in the trial reports, from correspondence all Almirall ‐sponsored trials applied a computer generated randomisation schedule which was prepared prior to initiating the trial.

Techniques: Control, Biomarker Discovery, Infection, Comparison, Medications, Sequencing, Selection, Generated, Blocking Assay

Journal: The Cochrane Database of Systematic Reviews

Article Title: Aclidinium bromide for stable chronic obstructive pulmonary disease

doi: 10.1002/14651858.CD010509.pub2

Figure Lengend Snippet: ACCORD COPD I

Article Snippet: Although not explicitly described in the trial reports, from correspondence all Almirall ‐sponsored trials applied a computer generated randomisation schedule which was prepared prior to initiating the trial.

Techniques: Control, Infection, Comparison, Medications, Sequencing, Selection, Generated, Blocking Assay

Journal: The Cochrane Database of Systematic Reviews

Article Title: Aclidinium bromide for stable chronic obstructive pulmonary disease

doi: 10.1002/14651858.CD010509.pub2

Figure Lengend Snippet: ACCORD COPD II

Article Snippet: Although not explicitly described in the trial reports, from correspondence all Almirall ‐sponsored trials applied a computer generated randomisation schedule which was prepared prior to initiating the trial.

Techniques: Control, Infection, Comparison, Medications, Concentration Assay, Sequencing, Selection, Generated, Blocking Assay

Journal: The Cochrane Database of Systematic Reviews

Article Title: Aclidinium bromide for stable chronic obstructive pulmonary disease

doi: 10.1002/14651858.CD010509.pub2

Figure Lengend Snippet: ACLIFORM

Article Snippet: Although not explicitly described in the trial reports, from correspondence all Almirall ‐sponsored trials applied a computer generated randomisation schedule which was prepared prior to initiating the trial.

Techniques: Control, Infection, Transplantation Assay, Functional Assay, Comparison, Sequencing, Selection, Generated, Blocking Assay

Journal: The Cochrane Database of Systematic Reviews

Article Title: Aclidinium bromide for stable chronic obstructive pulmonary disease

doi: 10.1002/14651858.CD010509.pub2

Figure Lengend Snippet: ATTAIN

Article Snippet: Although not explicitly described in the trial reports, from correspondence all Almirall ‐sponsored trials applied a computer generated randomisation schedule which was prepared prior to initiating the trial.

Techniques: Control, Biomarker Discovery, Infection, Comparison, Medications, Sequencing, Selection, Generated, Blocking Assay

Journal: The Cochrane Database of Systematic Reviews

Article Title: Aclidinium bromide for stable chronic obstructive pulmonary disease

doi: 10.1002/14651858.CD010509.pub2

Figure Lengend Snippet: AUGMENT COPD

Article Snippet: Although not explicitly described in the trial reports, from correspondence all Almirall ‐sponsored trials applied a computer generated randomisation schedule which was prepared prior to initiating the trial.

Techniques: Control, Infection, Comparison, Sequencing, Selection, Generated, Blocking Assay

Journal: The Cochrane Database of Systematic Reviews

Article Title: Aclidinium bromide for stable chronic obstructive pulmonary disease

doi: 10.1002/14651858.CD010509.pub2

Figure Lengend Snippet: Beier 2013

Article Snippet: Although not explicitly described in the trial reports, from correspondence all Almirall ‐sponsored trials applied a computer generated randomisation schedule which was prepared prior to initiating the trial.

Techniques: Control, Biomarker Discovery, Infection, Comparison, Medications, Sequencing, Selection, Generated, Blocking Assay

Journal: The Cochrane Database of Systematic Reviews

Article Title: Aclidinium bromide for stable chronic obstructive pulmonary disease

doi: 10.1002/14651858.CD010509.pub2

Figure Lengend Snippet: Chanez 2010

Article Snippet: Although not explicitly described in the trial reports, from correspondence all Almirall ‐sponsored trials applied a computer generated randomisation schedule which was prepared prior to initiating the trial.

Techniques: Control, Biomarker Discovery, Infection, Comparison, Medications, Activity Assay, Sequencing, Selection, Generated, Blocking Assay

Journal: The Cochrane Database of Systematic Reviews

Article Title: Aclidinium bromide for stable chronic obstructive pulmonary disease

doi: 10.1002/14651858.CD010509.pub2

Figure Lengend Snippet: NCT01572792

Article Snippet: Although not explicitly described in the trial reports, from correspondence all Almirall ‐sponsored trials applied a computer generated randomisation schedule which was prepared prior to initiating the trial.

Techniques: Control, Comparison, Sequencing, Selection, Generated, Blocking Assay

Journal: The Cochrane Database of Systematic Reviews

Article Title: Aclidinium bromide for stable chronic obstructive pulmonary disease

doi: 10.1002/14651858.CD010509.pub2

Figure Lengend Snippet: Sliwinski 2010

Article Snippet: Although not explicitly described in the trial reports, from correspondence all Almirall ‐sponsored trials applied a computer generated randomisation schedule which was prepared prior to initiating the trial.

Techniques: Control, Comparison, Sequencing, Selection